Results 181 to 190 of about 362,523 (334)

EP1.14-43 The Safety of First-line and Subsequent Monotherapy of PD-1/PD-L1 Inhibitors in NSCLC: A Meta Analysis [PDF]

, 2019
Yinfeng Yang, Zhilan Xie, Peter S. Pang, Na Wang, Huiying Liang, Lei Zhao   +5 more
openalex   +1 more source

Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives

Journal of Intelligent Medicine, EarlyView.
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan, Mohanad Ali Deifallah, Alaa Zaghloul, Rania Elgohary   +3 more
wiley   +1 more source

Actionable driver gene alterations in early-stage non-small cell lung cancer: a review. [PDF]

Ther Adv Med Oncol
Attili I, Pisapia P, Spitaleri G, Aliaga PT, Del Signore E, Napoli VM, Passaro A, Malapelle U, Troncone G, de Marinis F.   +9 more
europepmc   +1 more source

PV-0206 Gross endobronchial disease: predictor of clinical outcomes for early stage NSCLC treated with SBRT

, 2019
Nima Aghdam, Shaan Kataria, Monica Pernia, Carolyn Hall, Tracey L. O’Connor, L. Campbell, Simeng Suy, Sean P. Collins, Rebecca Krochmal, Eve Anderson, Jonathan W. Lischalk, Brian T. Collins   +11 more
openalex   +1 more source

Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p [PDF]

, 2020
Lili Zhou, Xing Chen, D Zhou, Rong Yang, Maohuai Cai   +4 more
openalex   +1 more source

Fortgeschrittenes NSCLC [PDF]

Wiener klinisches Magazin, 2016
openaire   +1 more source

Contrast‐Enhanced MR Fingerprinting With Delta‐Relaxometry: Investigating a New Avenue for Tumor Characterization

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background MRI contrast agents enhance lesion characterization by altering tissue relaxation properties. However, quantitative assessment of contrast enhancement is limited by variability in contrast administration parameters, and lack of efficient and precise contrast concentration independent relaxivity (r1, r2) measurement techniques.
Shengwen Deng, Walter Zhao, Sree Gongala, Jessie E. P. Sun, David W. Jordan, Chris A. Flask, Mark A. Griswold, Dan Ma, Chaitra Badve   +8 more
wiley   +1 more source

Zipalertinib-A Novel Treatment Opportunity for Non-Small Cell Lung Cancers with Exon 20 Insertions and Uncommon EGFR Mutations. [PDF]

Cancers (Basel)
Dempke WCM, Fenchel K, Reinmuth N.
europepmc   +1 more source

Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 106-118, March 2025.
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley   +1 more source

Understanding Non-Small-Cell Lung Cancer: Biology, Therapeutics and Drug Resistance. [PDF]

Biomedicines
Ahluwalia P, Kolhe R, Rojiani M.
europepmc   +1 more source